How ENTOD’s Year-Long Milestones have contributed to the growth of the Pharmaceutical Industry

July 9, 2022
● “ENTOD received an approval from the DCGI to start phase 3 clinical trials for 0.05% low-dose atropine eye drops 

● ENTOD aided Ukraine with medical supplies amidst the Russia-Ukraine war crisis

● ENTOD launched its “HyTek” ophthalmic super speciality surgical division 

● The company is planning to hire over 500 additional field-based sales workforce this financial year

● ENTOD launched its medical & cosmetics derma division “ENTOD Beauty London” in collaboration with its international research partners.”

Mumbai, July 09, 2022:

Established in the year 1977 by the late Mr G V Masurkar, ENTOD Pharmaceuticals will be celebrating its foundation day on 11th July on the occasion of the 100th birth anniversary of its founder. A visionary leader in the Indian pharmaceutical industry, Mr G V Masurkar’s continued passion for quality, research and innovation has propelled ENTOD Pharmaceuticals into a global brand with specialized expertise in the ENT, Ophthalmic and Dermatology medicine fields. Not to forget, he was also the man and brains behind the popular Indian paracetamol brand “CROCIN” which presently is a household painkiller brand in India.

ENTOD Pharmaceuticals will mark its 45th year in business, an exciting milestone for the company, its employees, and customers all over the world. ENTOD started as a contract manufacturer for sterile products (eye drops and injections) by establishing two manufacturing units on the outskirts of Mumbai.

However, it was during the late 1990s that it optimised its business model and started its own marketing & sales activities with a focus on developing and selling its own branded medicines. In early 2000, ENTOD massively upgraded its R&D facilities, quality systems and company protocols to increase its product range, marketing and sales activities and field-based representatives in order to increase its turnover.

Thereafter it continued to make impressive and consistent progress in both the Indian domestic as well as export markets and created a global name for itself in the ophthalmic, ENT & dermatology segments.

Recently, ENTOD received an approval from the DCGI to start phase 3 clinical trials for 0.05% low-dose atropine eye drops. If successful it will be the first one to launch these eye drops in India and in the world. ENTOD has also aided Ukraine with medical supplies amidst the Russia-Ukraine war crisis.

The company has also recently ventured into the ophthalmic surgical market through the launch of its super speciality surgical “HYTEK” division in order to further strengthen its position in the ophthalmology market. ENTOD Beauty London is another medical & cosmetic derma division initiative by ENTOD in collaboration with its international partners.

In the last 2 years the company has significantly expanded its product based with innovative technology-driven products including the launch of its nanotechnology-based under eye gel serum “Eyecirque” in early 2022.

Speaking on the occasion of the company’s foundation day, Nikkhil K Masurkar, Executive Director of ENTOD Pharmaceuticals said “Today ENTOD Pharmaceuticals is part of the ENTOD INTERNATIONAL Group together with our other sister concern research companies which have grown into an international research-based pharmaceutical organisation with over 4 decades of pharmaceutical expertise in Ophthalmology, ENT and Dermatology medicine.

In 2010, we started our UK and international operations that allowed us access to regulated markets, and considerably increased our export business. Since then the company has gone from strength to strength with a global reach spanning 55 countries worldwide including the UK & Europe. All these achievements have been made possible through the hard work and perseverance of all our employees, teams and workers. Thanks to everyone who supports us, each and every day. We couldn’t do it without you, and we are extremely grateful”.

“Globally, ENTOD has over 250 products in its portfolio, a global field force of over 1000 and highly experienced Quality Assurance, Production and R&D teams. Our quality systems are now certified in Europe and our manufacturing quality standards adhere to international GMP norms. Over the coming years, we are planning to increase our field strength by recruiting more employees and expand further into ophthalmic surgical & medical / cosmetic dermatology segments. This will further enable us to establish our stronghold in the domestic and international markets” he added.

“It’s been a long journey for ENTOD and it wouldn’t have been possible without the visionary approach of our founder and the immense contributions of all our employees. Being in the industry for more than four decades has taught us that innovation is the key not only to growth but also to strengthening our position in the market.

As part of our medium to long-term expansion plans, we are planning to enter the respiratory segment in the coming years too. Investment in R&D and new product development has already begun for respiratory products and we hope to start commercial activities in this segment by early 2024” said Mrs Anjula Masurkar, the clinical director of ENTOD Pharmaceuticals.

healthysoch

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Health Tips

Dr. T S Kler Padma Bhushan Awardee
MD, DM, MRCP, FRCP(U.K), FACC, D.Sc
Chairman – Fortis Heart Institute Gurugram

Precautions to avoid Corona Virus:

  1. Stay home as far as possible.
  2. Wash hands with soap and water frequently.
  3. Keep distance from people even your home members.
  4. Keep atleast 1-2 metres away from anybody coughing.
  5. Don’t touch your face, nose and mouth.

 

Dr. K.K Says

Archives

MonTueWedThuFriSatSun
    123
45678910
18192021222324
25262728293031
       
   1234
567891011
12131415161718
26272829   
       
891011121314
293031    
       
    123
45678910
11121314151617
25262728293031
       
  12345
6789101112
13141516171819
27282930   
       
      1
2345678
9101112131415
16171819202122
3031     
     12
17181920212223
24252627282930
31      
   1234
567891011
12131415161718
2627282930  
       
1234567
891011121314
22232425262728
293031    
       
     12
3456789
17181920212223
24252627282930
       
  12345
6789101112
       
  12345
13141516171819
2728     
       
      1
9101112131415
3031     
   1234
567891011
       
282930    
       
    123
45678910
       
  12345
27282930   
       
      1
3031     
    123
11121314151617
       
28      
       
2930     
       
    123
       
       
       
      1
9101112131415
3031     
     12
3456789
10111213141516
17181920212223
242526272829 
       
  12345
13141516171819
2728293031  
       
      1
23242526272829
3031     
    123
       
    123
25262728   
       
78910111213
28293031   
       
293031    
       
14151617181920
28293031   
       
   1234
567891011
       
   1234
567891011
262728    
       
891011121314
293031    
       
    123
18192021222324
25262728293031
       
  12345
27282930   
       
      1
2345678
16171819202122
3031     
    123
45678910
18192021222324
       
28293031   
       
     12
31      
   1234
       
  12345
6789101112
       
HealthySoch

Don't Miss

Integrating Ayush with other medicine systems will encourage quackery and disintegrate AYUSH

Integrating Ayush with other medicine systems will encourage quackery and disintegrate AYUSH

The IIPH has also come out in opposition of this

Hand sanitizers may not protect against flu virus

India healthysoch.com New Delhi, October 07, 2019 : Rubbing hands